STARTUP PROFILE

Nuuron

COUNTRY
Germany
FOUNDED
2023
CATEGORY
Neuromodulation
Developing a fully digital Alzheimer’s therapy that uses ultra-high-frequency digital-photonic stimulation via the retina, delivered through VR/AR, to activate memory systems.
Visit website →
Neurofounders Insights
$   Funding   -
Seed
MODALITY
Light/sound
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Dementia/impairment
TARGET USER
Patients
REGULATORY STAGE
Investigational
Nuuron is developing a fully digital Alzheimer’s therapy using photonic retinal stimulation delivered via VR/AR, making it one of the more unconventional entrants in dementia neuromodulation. Its approach is non-invasive and software-forward, but still very early.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Nuuron
No items found.